Task: Answer the multiple-choice question.
Query: Which drug exhibits a -0.659\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) CCNc1nc(NC(C)C)nc(NC(C)(C)C)n1
(b) Cc1cc(C(=O)Nc2ccncc2)ccc1[N+](=O)[O-]
Answer: b. Cc1cc(C(=O)Nc2ccncc2)ccc1[N+](=O)[O-]
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C(=O)Nc2ccncc2)ccc1[N+](=O)[O-]
Cc1cc(C(=O)Nc2ccncc2)ccc1[N+](=O)[O-]
[6-methyl-4-(pyridin-4-ylcarbamoyl)cyclohexa-1,3,5-trien-1-yl]-oxido-oxoazanium